Supplying trusted medical cannabis across regulated markets worldwide.
We grow better medicine.
Biogenetics Labs is an international medical cannabis company focused on raising standards of care for patients with unmet medical needs—providing a consistent supply of lab-tested cannabis products that clinicians and patients can rely on with confidence.
Quality
Cultivated in controlled, pharmaceutical-grade environments in South Africa, using proven genetics and validated cultivation methods. Every batch is supported by comprehensive laboratory testing to ensure medical-grade quality.
Consistency
Stable genetics, standardised operating procedures, and tightly controlled production cycles deliver reliable, repeatable outcomes—supporting predictable supply for European clinics and pharmacies.
Compliance
Our end-to-end supply chain is designed around European regulatory requirements, with documentation, testing, and quality oversight aligned to EU – GMP principles for import, release, and distribution into regulated European markets.
From South African cultivation to European patients - quality, consistency, and compliance at every step.
South Africa: Strategic Location & Workforce
A Deliberate Operating Base
Biogenetics Labs is based in South Africa by design. The location supports export-focused cultivation through:
- Purpose-built infrastructure aligned with EU regulatory expectations
- Access to experienced agricultural and technical talent
- A competitive cost structure that supports long-term scalability
South Africa enables efficiency without compromising quality or compliance.
People & Local Impact
Our operation is built around long-term investment in people and place.
We contribute to the local economy through:
- Stable, skilled employment across cultivation, quality, and operations
- Strong participation of women in operational and technical roles
- Ongoing training and capability development within the local workforce
All cultivation is hand-picked, a choice that ensures exceptional quality while also creating meaningful employment. Through structured training and on-site support, we develop skills locally and build careers rather than short-term labour.
This approach supports operational stability while establishing a capable, committed team rooted in the surrounding community.
Consistent Medical Cannabis, Released to EU-GMP Standards
Reliable medical cannabis isn’t defined by appearance — it’s defined by how consistently the flower performs for patients and how confidently it can be supplied into regulated markets.
Our flower is cultivated, finished and handled within a GMP-aligned quality system, designed to deliver predictable performance, batch-to-batch consistency and regulatory confidence for distributors, pharmacies and clinics.
Built for Distribution, Not Just Cultivation
Controlled drying and curing
Slow, validated drying and curing reduce residual chlorophyll and plant sugars, supporting smoother performance and stable cannabinoid and terpene profiles. These steps are defined, documented and repeatable within our QMS — not rushed to meet volume targets.
Moisture and stability control
Internal moisture is maintained within a narrow, validated range to support consistent vaporisation or combustion behaviour, reduce irritation, and protect shelf-life through distribution and storage.
Balanced cultivation inputs
Nutrient strategies are managed conservatively to avoid excess mineral residues that can affect performance. Finishing and flush protocols are defined, monitored and verified as part of routine batch documentation.
Structural integrity and handling
Flowers are handled to preserve internal structure and airflow, avoiding over-compression that can lead to inconsistent performance post-packaging and during patient use.
Trichome preservation
Post-harvest handling prioritises resin integrity, supporting terpene balance and gentler delivery — factors increasingly linked to patient adherence and repeat prescribing.
Quality You Can Release With Confidence
Beyond mandatory laboratory testing, our internal quality assessment includes practical performance indicators aligned with patient experience and distributor feedback, including:
- Even burn or vaporisation behaviour
- Clean residue profile
- Absence of harsh or acrid characteristics
- Predictable onset and duration
All outcomes are supported by documented SOPs, batch records, deviation handling and change control, ensuring traceability and audit readiness.
That’s the standard our quality system is built to deliver.
Why This Matters for Distributors
For wholesale and distribution partners, consistent flower performance means:
- Fewer quality complaints and returns
- More predictable patient feedback
- Stronger clinician confidence
- Reduced commercial and regulatory risk
In regulated markets, laboratory compliance is the baseline. What differentiates reliable supply is whether the product behaves consistently once it reaches the patient.